CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ZVRA — Zevra Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in ZVRA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,509,662
-$108,675 QoQ
Shares Held
161,981
-10.3% QoQ
Ownership
0.274%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. ZVRA ranks #187 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in ZVRA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,509,662 | 161,981 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,618,337 | 180,618 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,500,345 | 157,765 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,426,929 | 161,967 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,148,449 | 153,331 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,246,863 | 149,504 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $842,210 | 121,356 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $540,558 | 110,318 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $530,178 | 91,410 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $629,651 | 96,130 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $435,882 | 90,432 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $461,203 | 90,432 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $61,264 | 11,139 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $51,128 | 11,139 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $69,507 | 11,139 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $49,679 | 11,139 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $383,472 | 76,237 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $664,024 | 76,237 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $669,259 | 71,732 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $919,604 | 71,732 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||